These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1983462)

  • 1. Binding and covalent processing of fibrinogen by hepatocytes and endothelial cells.
    Barsigian C; Martinez J
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):551-5. PubMed ID: 1983462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. Use of 2-[(2-oxopropyl)thio] imidazolium derivatives as cellular transglutaminase inactivators.
    Barsigian C; Stern AM; Martinez J
    J Biol Chem; 1991 Nov; 266(33):22501-9. PubMed ID: 1682320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells.
    Martinez J; Rich E; Barsigian C
    J Biol Chem; 1989 Dec; 264(34):20502-8. PubMed ID: 2573600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of fibrinogen and fibronectin binding from transglutaminase-mediated cross-linking at the hepatocyte surface.
    Barsigian C; Fellin FM; Jain A; Martinez J
    J Biol Chem; 1988 Oct; 263(28):14015-22. PubMed ID: 2902077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and processing of fibrinogen by rabbit hepatocytes.
    Barsigian C; Fellin FM; Base W; Schaeffer A; Fish S; Martinez J
    J Biol Chem; 1987 Mar; 262(8):3674-9. PubMed ID: 3818660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligosaccharide valency and conformation in determining binding to the asialoglycoprotein receptor of rat hepatocytes.
    Rice KG; Lee YC
    Adv Enzymol Relat Areas Mol Biol; 1993; 66():41-83. PubMed ID: 8430516
    [No Abstract]   [Full Text] [Related]  

  • 7. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal surface distribution of the human asialoglycoprotein receptor in cirrhosis.
    Burgess JB; Baenziger JU; Brown WR
    Hepatology; 1992 Apr; 15(4):702-6. PubMed ID: 1372583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asialoglycoprotein receptor in human isolated hepatocytes from normal liver and its apparent increase in liver with histological alterations.
    Eisenberg C; Seta N; Appel M; Feldmann G; Durand G; Feger J
    J Hepatol; 1991 Nov; 13(3):305-9. PubMed ID: 1808223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic uptake of asialoglycoprotein is different among mammalian species due to different receptor distribution.
    Chang TM; Chang CL
    Biochim Biophys Acta; 1988 Jul; 942(1):57-64. PubMed ID: 3382658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study on the variables affecting toxicity of hybrid toxins. The effect of different target cell receptor distribution and toxin binding chain.
    Chang TM; Chang CH
    Biochim Biophys Acta; 1989 Oct; 1013(3):239-46. PubMed ID: 2804085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of experiments on kinetics of recycling of asialoglycoprotein receptors on the basis of a mathematical model].
    Alekhina LR; Kuznetsov VA
    Biofizika; 1990; 35(1):89-91. PubMed ID: 2161261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-intact CHO and endothelial cells: a tool to probe the control of integrin activity?
    Marie C; Tranqui L; Soyez S; Block MR
    Exp Cell Res; 1991 Jan; 192(1):173-81. PubMed ID: 1824586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histaminylation of fibrinogen by tissue transglutaminase-2 (TGM-2): potential role in modulating inflammation.
    Lai TS; Greenberg CS
    Amino Acids; 2013 Oct; 45(4):857-64. PubMed ID: 23797785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The asialoglycoprotein receptor: a model for endocytic transport receptors.
    Spiess M
    Biochemistry; 1990 Oct; 29(43):10009-18. PubMed ID: 2125488
    [No Abstract]   [Full Text] [Related]  

  • 16. Differential structural requirements for fibrinogen binding to platelets and to endothelial cells.
    Tranqui L; Andrieux A; Hudry-Clergeon G; Ryckewaert JJ; Soyez S; Chapel A; Ginsberg MH; Plow EF; Marguerie G
    J Cell Biol; 1989 Jun; 108(6):2519-27. PubMed ID: 2738096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-peptide fibrinogen receptor antagonists. 1. Discovery and design of exosite inhibitors.
    Hartman GD; Egbertson MS; Halczenko W; Laswell WL; Duggan ME; Smith RL; Naylor AM; Manno PD; Lynch RJ; Zhang G
    J Med Chem; 1992 Nov; 35(24):4640-2. PubMed ID: 1469694
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessment of receptor recycling in mammalian hepatocytes: perspectives based on current techniques.
    Harford J; Ashwell G
    Methods Enzymol; 1985; 109():232-46. PubMed ID: 3990566
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interaction of the hepatocyte asialoglycoprotein receptor with chemically galactosylated acid alpha-glucosidase].
    Bystrova NK
    Dokl Akad Nauk SSSR; 1985; 284(4):994-6. PubMed ID: 3910380
    [No Abstract]   [Full Text] [Related]  

  • 20. Asialoglycoprotein receptors in rat liver nodules.
    Andersson GN; Rissler P; Eriksson LC
    Carcinogenesis; 1988 Sep; 9(9):1623-8. PubMed ID: 3136945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.